116 related articles for article (PubMed ID: 16605263)
1. Activation of individual alphaIIbbeta3 integrin molecules by disruption of transmembrane domain interactions in the absence of clustering.
Litvinov RI; Vilaire G; Li W; DeGrado WF; Weisel JW; Bennett JS
Biochemistry; 2006 Apr; 45(15):4957-64. PubMed ID: 16605263
[TBL] [Abstract][Full Text] [Related]
2. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
Manaster Y; Shenkman B; Rosenberg N; Savion N
Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
[TBL] [Abstract][Full Text] [Related]
3. Activation of platelet alphaIIbbeta3 by an exogenous peptide corresponding to the transmembrane domain of alphaIIb.
Yin H; Litvinov RI; Vilaire G; Zhu H; Li W; Caputo GA; Moore DT; Lear JD; Weisel JW; Degrado WF; Bennett JS
J Biol Chem; 2006 Dec; 281(48):36732-41. PubMed ID: 17032655
[TBL] [Abstract][Full Text] [Related]
4. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
[TBL] [Abstract][Full Text] [Related]
5. Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations.
Li R; Mitra N; Gratkowski H; Vilaire G; Litvinov R; Nagasami C; Weisel JW; Lear JD; DeGrado WF; Bennett JS
Science; 2003 May; 300(5620):795-8. PubMed ID: 12730600
[TBL] [Abstract][Full Text] [Related]
6. The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation.
Vanhoorelbeke K; De Meyer SF; Pareyn I; Melchior C; Plançon S; Margue C; Pradier O; Fondu P; Kieffer N; Springer TA; Deckmyn H
J Biol Chem; 2009 May; 284(22):14914-20. PubMed ID: 19329429
[TBL] [Abstract][Full Text] [Related]
7. Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries.
Schwarz M; Röttgen P; Takada Y; Le Gall F; Knackmuss S; Bassler N; Büttner C; Little M; Bode C; Peter K
FASEB J; 2004 Nov; 18(14):1704-6. PubMed ID: 15522915
[TBL] [Abstract][Full Text] [Related]
8. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
[TBL] [Abstract][Full Text] [Related]
9. A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3.
Basani RB; French DL; Vilaire G; Brown DL; Chen F; Coller BS; Derrick JM; Gartner TK; Bennett JS; Poncz M
Blood; 2000 Jan; 95(1):180-8. PubMed ID: 10607701
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen interaction of CHO cells expressing chimeric alphaIIb/alphavbeta3 integrin.
Chen JJ; Su XY; Xi XD; Lin LP; Ding J; Lu H
Acta Pharmacol Sin; 2008 Feb; 29(2):204-10. PubMed ID: 18215349
[TBL] [Abstract][Full Text] [Related]
11. Construction of drug screening cell model and application to new compounds inhibiting FITC-fibrinogen binding to CHO cells expressing human alphaIIbbeta3.
Yang J; Yao J; Chen J; Wang XN; Zhu TY; Chen LL; Chu P
Eur J Pharmacol; 2009 Sep; 618(1-3):1-8. PubMed ID: 19619528
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-bound integrin-associated protein (CD47) physically and functionally modifies integrin alphaIIbbeta3 by its extracellular domain.
Fujimoto TT; Katsutani S; Shimomura T; Fujimura K
J Biol Chem; 2003 Jul; 278(29):26655-65. PubMed ID: 12736272
[TBL] [Abstract][Full Text] [Related]
13. A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin alphaIIbbeta3-dependent RhoA activation during cell spreading.
Salsmann A; Schaffner-Reckinger E; Kabile F; Plançon S; Kieffer N
J Biol Chem; 2005 Sep; 280(39):33610-9. PubMed ID: 15955823
[TBL] [Abstract][Full Text] [Related]
14. Regulation of integrins in platelets.
Bennett JS
Biopolymers; 2015 Jul; 104(4):323-33. PubMed ID: 26010651
[TBL] [Abstract][Full Text] [Related]
15. Differences in α-β transmembrane domain interactions among integrins enable diverging integrin signaling.
Kim C; Kim MC
Biochem Biophys Res Commun; 2013 Jul; 436(3):406-12. PubMed ID: 23747731
[TBL] [Abstract][Full Text] [Related]
16. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
Afrasiabi A; Gelain F; Artoni A; Mannucci PM
Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
[TBL] [Abstract][Full Text] [Related]
17. Multi-step fibrinogen binding to the integrin (alpha)IIb(beta)3 detected using force spectroscopy.
Litvinov RI; Bennett JS; Weisel JW; Shuman H
Biophys J; 2005 Oct; 89(4):2824-34. PubMed ID: 16040750
[TBL] [Abstract][Full Text] [Related]
18. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
[TBL] [Abstract][Full Text] [Related]
19. Effects of limiting extension at the alphaIIb genu on ligand binding to integrin alphaIIbbeta3.
Blue R; Li J; Steinberger J; Murcia M; Filizola M; Coller BS
J Biol Chem; 2010 Jun; 285(23):17604-13. PubMed ID: 20363746
[TBL] [Abstract][Full Text] [Related]
20. Effect of cytoplasmic domain mutations on the agonist-stimulated ligand binding activity of the platelet integrin alphaIIbbeta3.
Loh E; Qi W; Vilaire G; Bennett JS
J Biol Chem; 1996 Nov; 271(47):30233-41. PubMed ID: 8939976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
